C57BL/6JCya-Cbr3em1flox/Cya
Common Name:
Cbr3-flox
Product ID:
S-CKO-00807
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cbr3-flox
Strain ID
CKOCMP-109857-Cbr3-B6J-VA
Gene Name
Product ID
S-CKO-00807
Gene Alias
1110001J05Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
16
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cbr3em1flox/Cya mice (Catalog S-CKO-00807) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000039620
NCBI RefSeq
NM_173047
Target Region
Exon 3
Size of Effective Region
~1.6 kb
Detailed Document
Overview of Gene Research
Cbr3, also known as carbonyl reductase 3, is involved in various biological processes and diseases. Its single nucleotide polymorphism (V244M) has been linked to the risk of anthracycline-related cardiomyopathy, with the CBR3 V244M genotype status associated with changes in echocardiographic parameters suggestive of early anthracycline-related cardiomyopathy in breast cancer patients undergoing chemotherapy [5].
The long non-coding RNA CBR3-AS1, which is related to Cbr3, has been found to play oncogenic roles in multiple cancers. In gestational choriocarcinoma, it accelerates malignant proliferation by stabilizing SETD4 [1]. In osteosarcoma, it promotes stemness, EMT, and tumor growth through the miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway [2]. In cervical cancer, high expression of CBR3-AS1 predicts poor prognosis and promotes cancer progression through the miR-3163/LASP1 pathway [4]. In lung adenocarcinoma, it potentiates Wnt/β-catenin signaling to regulate cell proliferation, migration, and invasion [6]. In colorectal cancer, it promotes stem-like properties and oxaliplatin resistance by sponging miR-145-5p [7]. In breast cancer, it regulates drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway [8]. In ulcerative colitis, it promotes and enhances malignancy by targeting miRNA-145-5p/FN1 [3]. Additionally, allicin affects the immunoreactivity of osteosarcoma cells through the CBR3-AS1/miR-145-5p/GRP78 axis [9].
In conclusion, Cbr3 and its related lncRNA CBR3-AS1 are involved in multiple biological processes and play important roles in various diseases, especially in cancer progression and drug-related cardiotoxicity. Studies on these genes help to understand the mechanisms of disease occurrence and may provide new strategies for treatment.
References：
1. Zhang, Yajuan, Zhang, Hongxiu, Zhang, Xiaolei, Liu, Bin. 2022. CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4. In Disease markers, 2022, 7155525. doi:10.1155/2022/7155525. https://pubmed.ncbi.nlm.nih.gov/35655916/
2. Yao, Weitao, Hou, Jingyu, Liu, Guoqing, Guo, Liangyu, Wang, Chuchu. 2022. LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway. In Molecular therapy oncolytics, 25, 189-200. doi:10.1016/j.omto.2022.03.001. https://pubmed.ncbi.nlm.nih.gov/35592388/
3. Cao, Jingmei, Zhao, Qing, Jia, Qing, Li, Yiming. 2023. LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1. In Cellular and molecular biology (Noisy-le-Grand, France), 69, 181-186. doi:10.14715/cmb/2023.69.7.29. https://pubmed.ncbi.nlm.nih.gov/37715388/
4. Cai, Yipin, Huang, Yu, Zhang, Jie, Huang, Haiwei, Gao, Yu. . LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway. In Neoplasma, 69, 1406-1417. doi:10.4149/neo_2022_220730N784. https://pubmed.ncbi.nlm.nih.gov/36591804/
5. Lang, Jennifer K, Karthikeyan, Badri, Quiñones-Lombraña, Adolfo, Blanco, Javier G, O'Connor, Tracey. 2021. CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin. In Cardio-oncology (London, England), 7, 17. doi:10.1186/s40959-021-00103-0. https://pubmed.ncbi.nlm.nih.gov/33975650/
6. Hou, Min, Wu, Nannan, Yao, Lili. 2021. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion. In Cancer cell international, 21, 36. doi:10.1186/s12935-020-01685-y. https://pubmed.ncbi.nlm.nih.gov/33422081/
7. Xie, Liangbao, Cui, Guangfei, Li, Tao. 2022. Long Noncoding RNA CBR3-AS1 Promotes Stem-like Properties and Oxaliplatin Resistance of Colorectal Cancer by Sponging miR-145-5p. In Journal of oncology, 2022, 2260211. doi:10.1155/2022/2260211. https://pubmed.ncbi.nlm.nih.gov/35466320/
8. Zhang, Ming, Wang, Yan, Jiang, Longyang, Wei, Minjie, Zhao, Lin. 2021. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway. In Journal of experimental & clinical cancer research : CR, 40, 41. doi:10.1186/s13046-021-01844-7. https://pubmed.ncbi.nlm.nih.gov/33494806/
9. Xie, Wenpeng, Ma, Fengjun, Dou, Luming, Zhang, Zhimeng, Zhang, Yongkui. 2024. Allicin affects immunoreactivity of osteosarcoma cells through lncRNA CBR3-AS1. In Heliyon, 10, e31971. doi:10.1016/j.heliyon.2024.e31971. https://pubmed.ncbi.nlm.nih.gov/38947424/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen